All Stories

  1. PCSK9 Inhibition could be Effective for Acute Myocardial Infarction

    Article • Current Medicinal Chemistry, February 2022, Bentham Science Publishers

    Dr Baris Gencer

  2. Prognostic value of total testosterone levels in patients with acute coronary syndromes

    Article • European Journal of Preventive Cardiology, June 2019, SAGE Publications

    Dr Baris Gencer

  3. Prognostic values of fasting hyperglycaemia in non-diabetic patients with acute coronary syndrome: A prospective cohort study

    Article • European Heart Journal Acute Cardiovascular Care, June 2018, SAGE Publications

    Dr Baris Gencer

  4. Eligibility for PCSK9 Inhibitors According to American College of Cardiology (ACC) and European Society of Cardiology/European Atherosclerosis Society (ESC/EAS) Guidelines After Acute Coronary Syndromes

    Article • Journal of the American Heart Association, November 2017, Wolters Kluwer Health

    Dr Baris Gencer

  5. Association between resistin levels and cardiovascular disease events in older adults: The health, aging and body composition study

    Article • Atherosclerosis, February 2016, Elsevier

    Dr Baris Gencer

  6. Prognostic value of PCSK9 levels in patients with acute coronary syndromes

    Article • European Heart Journal, December 2015, European Society of Cardiology

    Dr Baris Gencer, Dr Federico Carbone

  7. Testosterone: a hormone preventing cardiovascular disease or a therapy increasing cardiovascular events?

    Article • European Heart Journal, December 2015, European Society of Cardiology

    Dr Baris Gencer

  8. 2015 ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-segment Elevation

    Article • Revista Española de Cardiología (English Edition), December 2015, Elsevier

    Dr Baris Gencer

  9. Guía ESC 2015 sobre el tratamiento de los síndromes coronarios agudos en pacientes sin elevación persistente del segmento ST

    Article • Revista Española de Cardiología, December 2015, Elsevier

    Dr Baris Gencer, Professor Raffaele Bugiardini, Prof HECTOR BUENO

  10. TCT-257 Frequency and clinical impact of prasugrel cessation after primary PCI in STEMI patients: a prospective cohort study

    Article • Journal of the American College of Cardiology, October 2015, Elsevier

    Dr Baris Gencer

  11. Coronary artery disease is associated with persistent lower quality of life in women

    Article • Open Heart, September 2015, BMJ

    Dr Baris Gencer

  12. Stairs instead of elevators at the workplace decreases PCSK9 levels in a healthy population

    Article • European Journal of Clinical Investigation, August 2015, Wiley

    Dr Baris Gencer

  13. Low statin use in adults hospitalized with acute coronary syndrome

    Article • Preventive Medicine, August 2015, Elsevier

    Dr Baris Gencer

  14. Electrocardiographic screening for drug-induced long qt to reduce sudden cardiac death in Psychiatric patients: a cost-effectiveness analysis

    Article • Clinical Therapeutics, August 2015, Elsevier

    Dr Baris Gencer

  15. Correction: Electrocardiographic Screening for Prolonged QT Interval to Reduce Sudden Cardiac Death in Psychiatric Patients: A Cost-Effectiveness Analysis

    Article • PLoS ONE, July 2015, PLOS

    Dr Baris Gencer

  16. Prevalence and management of familial hypercholesterolaemia in patients with acute coronary syndromes

    Article • European Heart Journal, July 2015, European Society of Cardiology

    Dr Baris Gencer

  17. Electrocardiographic Screening for Prolonged QT Interval to Reduce Sudden Cardiac Death in Psychiatric Patients: A Cost-Effectiveness Analysis

    Article • PLoS ONE, June 2015, PLOS

    Dr Baris Gencer

  18. PCSK9 inhibitors

    Article • Swiss Medical Weekly, April 2015, EMH Swiss Medical Publishers, Ltd.

    Dr Baris Gencer

  19. Sweetless'n low LDL-C targets for PCSK9 treatment : Figure 1

    Article • European Heart Journal, March 2015, European Society of Cardiology

    Dr Baris Gencer

  20. Safety profile of prasugrel and clopidogrel in patients with acute coronary syndromes in Switzerland

    Article • Heart, March 2015, BMJ

    Dr Baris Gencer

  21. Expected impact of applying new 2013 AHA/ACC cholesterol guidelines criteria on the recommended lipid target achievement after acute coronary syndromes

    Article • Atherosclerosis, March 2015, Elsevier

    Dr Baris Gencer

  22. Reasons for discontinuation of recommended therapies according to the patients after acute coronary syndromes

    Article • European Journal of Internal Medicine, January 2015, Elsevier

    Dr Baris Gencer

  23. Association of electrocardiogram abnormalities and incident heart failure events

    Article • American Heart Journal, June 2014, Elsevier

    Dr Baris Gencer

  24. Quality of Care after Acute Coronary Syndromes in a Prospective Cohort with Reasons for Non-Prescription of Recommended Medications

    Article • PLoS ONE, March 2014, PLOS

    Dr Baris Gencer

  25. TCT-4 Efficacy and Safety of Concurrent Administration of Clopidogrel-loading (600mg) and Prasugrel-loading (60mg) in Patients with Acute ST-Segment Elevation Myocardial Infarction

    Article • Journal of the American College of Cardiology, October 2013, Elsevier

    Dr Baris Gencer

  26. Subclinical Thyroid Dysfunction and Cardiovascular Outcomes among Prospective Cohort Studies

    Article • Endocrine Metabolic & Immune Disorders - Drug Targets, March 2013, Bentham Science Publishers

    Dr Baris Gencer

  27. Subclinical Thyroid Dysfunction and the Risk of Heart Failure Events: An Individual Participant Data Analysis From 6 Prospective Cohorts

    Article • Circulation, July 2012, Wolters Kluwer Health

    Dr Baris Gencer

  28. Subclinical Hyperthyroidism and the Risk of Coronary Heart Disease and Mortality

    Article • Archives of Internal Medicine, May 2012, American Medical Association (AMA)

    Dr Baris Gencer, sabrina molinaro

  29. Ruling out coronary heart disease in primary care patients with chest pain: a clinical prediction score

    Article • BMC Medicine, January 2010, Springer Science + Business Media

    Dr Baris Gencer